Explanatory note on new interim order to advance COVID-19 clinical trials
IO No. 2 supports Canada’s continued focus on dealing with the significant risk that COVID-19 continues to pose to the health and safety of Canadians.
Organization:
Health Canada
Resource Formats:
- HTML